• Paul Ellis Marik


Posterior reversible encephalopathy syndrome (PRES), first described by Hinchey and colleagues in 1996, is a clinico-neuro-radiological entity characterized by headache, vomiting, altered mental status, blurred vision, and seizures with neuroimaging studies, demonstrating white–gray matter edema involving predominantly the posterior region of the brain.1 PRES is most commonly associated with pre-eclampsia, hypertensive encephalopathy, and immunosuppressive/cytotoxic drugs.2–4 One of the distinctive characteristics of PRES is the reversibility of the clinical and radiological abnormalities once treatment is instituted. Most patients usually make a complete recovery within few weeks. A delay in the recognition and treatment of the syndrome may result in permanent neurological sequela.


Status Epilepticus Posterior Reversible Encephalopathy Syndrome Refractory Status Epilepticus Hypertensive Encephalopathy Pyrimidine Nucleoside 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494–500.PubMedCrossRefGoogle Scholar
  2. 2.
    Servillo G, Bifulco F, De Robertis E, et al. Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med. 2007;33:230–236.PubMedCrossRefGoogle Scholar
  3. 3.
    Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR. 2008;29:1036–1042.PubMedCrossRefGoogle Scholar
  4. 4.
    Gocmen R, Ozgen B, Oguz KK. Widening the spectrum of PRES: series from a tertiary care center. Eur J Radiol. 2007;62:454–459.PubMedCrossRefGoogle Scholar
  5. 5.
    Bartynski WS, Boardman JF, Zeigler ZR, et al. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR. 2006;27:2179–2190.PubMedGoogle Scholar
  6. 6.
    Servillo G, Striano P, Striano S, et al. Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients. Intensive Care Med. 2003;29:2323–2326.PubMedCrossRefGoogle Scholar
  7. 7.
    Celik M, Forta H, Dalkilic T, et al. MRI reveals reversible lesions resembling posterior reversible encephalopathy in porphyria. Neuroradiology. 2002;44:839–841.PubMedCrossRefGoogle Scholar
  8. 8.
    Chawla R, Smith D, Marik PE. Near fatal posterior reversible encephalopathy syndrome complicating chronic liver failure treated by induced hypothermia and dialysis: a case report. J Med Case Rep. 2009;3:6623.Google Scholar
  9. 9.
    Baizabal-Carvallo JF, Barragan-Campos HM, Padilla-Aranda HJ, et al. Posterior reversible encephalopathy syndrome as a complication of acute lupus activity. Clin Neurol Neurosurg. 2009;111:359–363.PubMedCrossRefGoogle Scholar
  10. 10.
    McKinney AM, Short J, Truwit CL, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR. 2007;189:904–912.PubMedCrossRefGoogle Scholar
  11. 11.
    Casey SO, Sampaio RC, Michel E, et al. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol. 2000;21:1199–1206.PubMedGoogle Scholar
  12. 12.
    Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR. 2002;23:1038–1048.PubMedGoogle Scholar
  13. 13.
    Finsterer J, Schlager T, Kopsa W, et al. Nitroglycerin-aggravated pre-eclamptic posterior reversible encephalopathy syndrome (PRES). Neurology. 2003;61:715–716.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Division of Pulmonary and Critical Care MedicineEastern Virginia Medical SchoolNorfolkUSA

Personalised recommendations